SELARL PHARMACIE BLETHON RICHARD : revenue, balance sheet and financial ratios

SELARL PHARMACIE BLETHON RICHARD is a French company founded 21 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in CHAMPAGNOLE (39300), this company of category PME shows in 2024 a revenue of 3.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE BLETHON RICHARD (SIREN 481376127)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C 3 312 193 € 2 813 967 € 2 810 242 € 2 433 973 € 2 356 269 € 2 239 376 € 2 205 089 € 2 227 011 € 2 226 640 €
Net income 76 535 € 271 € 113 933 € 202 484 € 68 960 € 67 195 € 89 707 € 116 867 € 77 576 € 78 803 €
EBITDA N/C 208 058 € 129 228 € 265 668 € 85 230 € 53 737 € 75 937 € 121 692 € 66 501 € 71 345 €
Net margin N/C 0.0% 4.0% 7.2% 2.8% 2.9% 4.0% 5.3% 3.5% 3.5%

Revenue and income statement

In 2025, SELARL PHARMACIE BLETHON RICHARD generates positive net income of 77 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 79 k€ -> 77 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

76 535 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 43%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 58%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

42.569%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

58.297%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

31.5%

Solvency indicators evolution
SELARL PHARMACIE BLETHON RICHARD

Sector positioning

Debt ratio
42.57 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good +10 pts over 3 years

In 2025, the debt ratio of SELARL PHARMACIE BLETHON ... (42.57) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
58.3% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good -7 pts over 3 years

In 2025, the financial autonomy of SELARL PHARMACIE BLETHON ... (58.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
2.21 years 2024
2023
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Good -6 pts over 2 years

In 2024, the repayment capacity of SELARL PHARMACIE BLETHON ... (2.21) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 146.76. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

146.763

Liquidity indicators evolution
SELARL PHARMACIE BLETHON RICHARD

Sector positioning

Liquidity ratio
146.76 2025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average +11 pts over 3 years

In 2025, the liquidity ratio of SELARL PHARMACIE BLETHON ... (146.76) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
5.25x 2024
2023
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Good +19 pts over 2 years

In 2024, the interest coverage of SELARL PHARMACIE BLETHON ... (5.2x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 35 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 545 days. Excellent situation: suppliers finance 510 days of the operating cycle (retail model).

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

35 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

545 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE BLETHON RICHARD

Positioning of SELARL PHARMACIE BLETHON RICHARD in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE BLETHON RICHARD is estimated at 1 215 767 € (range 825 025€ - 1 907 706€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
825k€ 1215k€ 1907k€
1 215 767 € Range: 825 025€ - 1 907 706€
NAF 5 année 2025

Valuation method used

Net Income Multiple
76 535 € × 15.9x = 1 215 768 €
Range: 825 026€ - 1 907 707€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE BLETHON RICHARD with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE BLETHON RICHARD

What is the revenue of SELARL PHARMACIE BLETHON RICHARD ?

The revenue of SELARL PHARMACIE BLETHON RICHARD in 2024 is 3.3 M€.

Is SELARL PHARMACIE BLETHON RICHARD profitable?

Yes, SELARL PHARMACIE BLETHON RICHARD generated a net profit of 77 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE BLETHON RICHARD ?

The headquarters of SELARL PHARMACIE BLETHON RICHARD is located in CHAMPAGNOLE (39300), in the department Jura.

Where to find the tax return of SELARL PHARMACIE BLETHON RICHARD ?

The tax return of SELARL PHARMACIE BLETHON RICHARD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE BLETHON RICHARD operate?

SELARL PHARMACIE BLETHON RICHARD operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.